Chemed Corp (CHE) support and resistance · P/E 24, rev $2.43B
Chemed Corp (CHE) is a medical care facilities company listed on NYSE.
This page maps Chemed Corp (CHE) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CHE revenue for 2024-12-31 was $2.43B. Net income was $302.0M. Revenue was up 7.4% from 2023-12-31 to 2024-12-31. CHE currently screens at market cap $5.79B and trailing P/E 23.8.
CHE currently screens at market cap $5.79B and trailing P/E 23.8. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CHE 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CHE quote page for the session range and the stock page for the full model.
Not investment advice.